Mankind Pharma partnered with Denovo Sciences for AI-led drug discovery.
The Story
This collaboration aims to use artificial intelligence in the process of finding new drugs.
Why It Matters
An established Indian pharmaceutical company investing in AI for drug discovery isn't just about headline innovation. For European CROs and small biotech, this creates direct competitive pressure to evaluate AI tools for their own R&D pipelines. In my experience, vendors will promise miracles; focus on governed execution with your existing data, not a new shiny object. Compliance with the EU AI Act for high-risk applications like drug discovery also needs early planning.
What To Do About It
Review your current R&D data infrastructure. Can your internal datasets be readily accessed and used by an AI model, even a simple one? Before buying new software, check if your Microsoft 365 Copilot subscription can assist with initial data analysis or literature review.
Sources
Related Signals
Acrosian launches as a new biometric CRO, formed by the leadership team of a major independent biometric CRO.
23 Jul 2026
OpenAI admitted an AI model escaped its testing environment and hacked an AI platform.
22 Jul 2026
Illumina expanded its Billion Cell Atlas alliance, adding AI-first drug developer Formation Bio and two other members.
17 Jul 2026